Out-patient Therapy of Iatrogenic Opioid Dependency following Prolonged Sedation in the Pediatric Intensive Care Unit

1996 ◽  
Vol 11 (5) ◽  
pp. 284-287 ◽  
Author(s):  
Joseph D. Tobias

As a result of heightened awareness of the need for aggressive sedation and analgesia in the pediatric intensive care unit population, the risk for opioid withdrawal continues to increase. Although gradual tapering of the intravenous dose of opioid can be used to prevent such problems, this approach mandates maintenance of intravenous access and in-patient hospital admission. I present experience with the out-patient use of oral methadone to prevent opioid withdrawal following prolonged fentanyl sedation in the pediatric intensive care unit. A cohort of 18 patients is reviewed, and suggested guidelines for out-patient management of these patients using oral methadone are presented.

1995 ◽  
Vol 10 (6) ◽  
pp. 294-314 ◽  
Author(s):  
Joseph D. Tobias

Several situations arise in the Pediatric Intensive Care Unit (PICU) patient which may require the pharmacologic control of pain and anxiety. The author discusses the various pharmacologic agents available for sedation and analgesia including the inhalational anesthetic agents, nitrous oxide, benzodiasepines, opioids, ketamine, propofol, and the barbiturates. While intravenous administration is generally chosen for the PICU patient, certain situations may arise which preclude this route. The available information concerning alternative routes of delivery for the various agents including subcutaneous and transmucosal administration is presented. The role of various regional anesthetic techniques to control pain in the PICU patient are reviewed.


2006 ◽  
Vol 2 (4) ◽  
pp. 201 ◽  
Author(s):  
Joseph D. Tobias, MD

This retrospective study aims to report on the use of dexmedetomidine to treat opioid withdrawal following sedation during mechanical ventilation in a cohort of infants. Seven infants in the pediatric intensive care unit of a tertiary care center, ranging in age from three to 24 months (12.4 ± 8.2 months) and in weight from 4.6 to 15.4 kgs (9.9 ± 4.2 kgs), had received a continuous fentanyl infusion, supplemented with intermittent doses of midazolam for sedation, during mechanical ventilation. Withdrawal was documented by a Finnegan score ³ 12. Dexmedetomidine was administered as a loading dose of 0.5 mg/kg/hr, followed by an infusion of 0.5 mg/kg/hr.Dexmedetomidine effectively controlled the signs and symptoms of withdrawal in the seven patients. Subsequent Finnegan scores were £ 7 at all times (median 4, range 1 to 7). Two patients required a repeat of the loading dose and an increase of the infusion to 0.7 mg/kg/hr. These two patients had received higher doses of fentanyl than the other five patients (8.5 ± 0.7 versus 4.6 ± 0.5 mg/kg/hr, p < 0.0005). No adverse hemodynamic or respiratory effects related to dexmedetomidine were noted.This report involves the largest cohort of patients to receive dexmedetomidine in the treatment of withdrawal following opioid and benzodiazepine sedation during mechanical ventilation. We conclude that dexmedetomidine offers a viable option for such issues in the pediatric intensive care unit (PICU) setting.


2017 ◽  
Vol 27 (11) ◽  
pp. 1098-1107
Author(s):  
Robert B. Flint ◽  
Carole N. M. Brouwer ◽  
Anne S. C. Kränzlin ◽  
Loraine Lie-A-Huen ◽  
Albert P. Bos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document